SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001493152-23-033501 from Syra Health Corp (SYRA) (CIK 0001922335) (SYRA)

Syra Health Corp (SYRA) (CIK 0001922335)
Date: Sept. 22, 2023 · CIK: 0001922335 · Accession: 0001493152-23-033501

AI Filing Summary & Sentiment

File numbers found in text: 333-271622

Date
Sept. 22, 2023
Author
Kingswood
Form
CORRESP
Company
Syra Health Corp (SYRA) (CIK 0001922335)

Letter

September 22, 2023

VIA EDGAR

United States Securities and Exchange Commission

F. Street, NE

Washington, DC 20549

Attn: Scott Stringer

Joel Parker

Brian Fetterolf

Erin Jaskot

Re: Syra Health Corp.

Registration Statement on Form S-1, as amended

File No. 333-271622

Ladies and Gentlemen:

As representative of the several underwriters of the proposed offering of Syra Health Corp. (the “Company”), we hereby join the Company’s request for acceleration of the above-referenced Registration Statement, requesting effectiveness at 4:30 p.m., Eastern Time, on Tuesday, September 26, 2023, or as soon thereafter as possible.

The undersigned advise that they have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

[Signature Page Follows]

Sincerely,
Kingswood,
a division of Kingswood Capital Partners, LLC

Show Raw Text
CORRESP
1
filename1.htm

September
22, 2023

VIA
EDGAR

United
States Securities and Exchange Commission

100
F. Street, NE

Washington,
DC 20549

    Attn:
    Scott Stringer

    Joel Parker

    Brian Fetterolf

    Erin Jaskot

    Re:
    Syra
    Health Corp.

    Registration
    Statement on Form S-1, as amended

    File
    No. 333-271622

Ladies
and Gentlemen:

As
representative of the several underwriters of the proposed offering of Syra Health Corp. (the “Company”), we
hereby join the Company’s request for acceleration of the above-referenced Registration Statement, requesting effectiveness at
4:30 p.m., Eastern Time, on Tuesday, September 26, 2023, or as soon thereafter as possible.

The
undersigned advise that they have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as
amended.

[Signature
Page Follows]

    Sincerely,

    Kingswood,
    a division of Kingswood Capital Partners, LLC

    By:
    /s/
    Tyler Bashaw

    Name:
    Tyler
Bashaw

    Title:
    Director

[Signature
Page to Acceleration Request]